x

Cancer Research

Highlights from #ASCO15

The American Society of Clinical Oncology held their Annual Meeting May 29-June 2 in Chicago. Here are some of the highlights, as told by the physicians who attended the meeting. Patient Reported Outcomes, Genetics, and Social Media Dr. Sarah Hawley  @Hawleysaraht  ASCO 2015 had some very interesting sessions covering patient-reported outcomes, decision-making and general health services […]

Read more ›
Updates from #AACR15

by Lori Marx-Rubiner and Dr. Emil Lou The 2015 meeting of the American Association for Cancer Research was held in Philadelphia April 18th – 22nd. Lori Marx-Rubiner attended the conference – here are her thoughts: In the “Breaking News” department – at least as pertains to breast cancer – I thought this year’s AACR was […]

Read more ›
#BCSM Spotlight – Dr. Oliver Bogler

Tell us about your breast cancer experience, including diagnosis and treatment In 2012 I was diagnosed with stage III ductal carcinoma ER+/PR+, Her2-, at age 46 and underwent standard treatment at MD Anderson: first 6 months of chemotherapy (taxol followed by FAC), then mastectomy, then 6 weeks of radiation and now tamoxifen. I currently have […]

Read more ›
Highlights from #SSO2015
On: Apr 6, 2015
By: bcsmadmin

Drs. Deanna Attai and Michael Cowher share their impressions from the Society of Surgical Oncology 2015 Annual Meeting, held March 25-28 in Houston. Neoadjuvant Therapy for Breast Cancer: Dr. Elizabeth Mittendorf started the session with an overview of neoadjuvant therapy. Neoadjuvant therapy refers to treatment prior to surgery. While traditionally this has been reserved for patients […]

Read more ›
Journal of the National Cancer Institute Report
On: Mar 30, 2015
By: DrAttai

Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty and State Today, the Journal of the National Cancer Institute (JNCI) released a report reviewing cancer data, specifically breast cancer, from 1975-2011. For the first time, data regarding breast cancer subtypes was included in the report, […]

Read more ›